New research by Cyprotex in the field of metformin drug-drug interactions has been published in Pharmacology Research & Perspectives. The publication assists in further understanding the mechanism behind clinically observed DDIs with the common co-medication, metformin.
Read our blog and download the publication.
Cyprotex offers a full range of in vitro ADME, DDI and toxicology services including both screening and regulatory support:
ADME and DDI
- Drug metabolism
- Permeability and transporters
- DDI studies
- Distribution and protein binding
- Solubility and physicochemical properties
- In silico predictions
- High content screening
- Microelectrode array
- 2D and 3D cell-based models
- Organ specific toxicity
- Mechanistic toxicology